- Lipotec invested €12M in a new plant at Gava, Spain.
- The plant spans 16,000 sq ft and will employ 80 people.
- Production capacity will triple in the next two years.
- Lipotec produces liposomes and peptides, exporting 80% of its output.
Investment and Location
Spanish pharmaceutical firm Lipotec has invested €12 million to construct a new plant in Gava, near Barcelona. This strategic investment aims to enhance the company's production capabilities and meet growing market demands.
Plant Specifications
The new facility spans 16,000 square feet (1,440 square meters) and will employ approximately 80 people. This expansion is expected to significantly boost the local economy by creating new job opportunities.
Production Capacity
With the new plant, Lipotec plans to triple its total production capacity over the next two years. This increase will enable the company to better serve its clients in various industries, including cosmetics, pharmaceuticals, and food.
Product Focus
Lipotec specializes in producing raw materials such as liposomes and peptides. These materials are essential components in a wide range of products, from skincare formulations to pharmaceutical applications.
Export Market
Currently, 80% of Lipotec's products are exported outside Spain. This global reach underscores the company's strong international presence and its commitment to maintaining high standards in product quality and innovation.
